{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:13:20Z","timestamp":1792548800392,"version":"4.5.0"},"reference-count":89,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2023,6,3]]},"DOI":"10.1080\/17512433.2023.2219054","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T06:13:23Z","timestamp":1686204803000},"page":"549-558","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["TYK2 as a novel therapeutic target in psoriasis"],"prefix":"10.1080","volume":"16","author":[{"given":"Sarah","family":"Elyoussfi","sequence":"first","affiliation":[{"name":"Dermatology Centre, Northern Care Alliance NHS Foundation Trust, 2 NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shraddha S","family":"Rane","sequence":"additional","affiliation":[{"name":"Centre for Genetics and Genomics versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Eyre","sequence":"additional","affiliation":[{"name":"Centre for Genetics and Genomics versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2918-6481","authenticated-orcid":false,"given":"Richard B","family":"Warren","sequence":"additional","affiliation":[{"name":"Dermatology Centre, Northern Care Alliance NHS Foundation Trust, 2 NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,6,7]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32279-7"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.743180"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(85)70188-0"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10069"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag1974"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800013"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00791-1"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1002\/pro.3519"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646680"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201546070"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1038\/nm804"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.308"},{"key":"cit0013","unstructured":"FDA. SOTYKTU\u2122 (deucravacitinib) tablets, for oral use. Initial U.S. Approval: 2022. [cited 2022 May 2]; Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/214958s000lbl.pdf"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2467"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00044"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15382"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61128-3"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2008.01215.x"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.82"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8010115"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12375"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1159\/000022832"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2020.05.008"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.11.007"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1086\/511051"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(02)00072-5"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1038\/ng.694"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2827"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2014.07.002"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3576"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.10.001"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2014.08.005"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1038\/ng.1076"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017160"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1126\/science.1135245"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.080283"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.170"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1101\/gr.136127.111"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-060815-014607"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt520"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1879-7"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax4588"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3314"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2667"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1038\/ng.717"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2770"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122271"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3245"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2012.01.056"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1038\/377591a0"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5332.1630"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.03.013"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003244"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81166-6"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.4331\/wjbc.v13.i1.1"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01468"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1038\/nm0596-561"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.21"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1177\/2040620712461047"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0835-9"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.06.045"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0908-4"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare9111575"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00444"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.07.002"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.25251\/skin.6.supp.48"},{"key":"cit0067","unstructured":"Myers Squibb B. An investigational study to evaluate experimental medication BMS-986165 in Japanese participants with moderate-to-severe psoriasis. [cited 2023 Jan 2]; https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT039244272022"},{"key":"cit0068","author":"Mease P","year":"2020","journal-title":"Annals of the Rheumatic Diseases"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.03.962"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.03.059"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2083"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-017-2226-2"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1806382"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.11.001"},{"key":"cit0075","unstructured":"Bristol Myers Squibb announces deucravacitinib (BMS-986165) demonstrated superiority to placebo and otezla\u00ac\u00a8\u221a\u00dc (apremilast) in Pivotal phase 3 psoriasis study\u00ac\u00a8\u201a\u00c4\u2020 [Internet]. Bristol-Myers Squibb; 2020; Nov 3, 2020 [cited May 2, 2022]. 2020: https:\/\/news.bms.com\/news\/details\/2020\/Bristol-Myers-Squibb-Announces-Deucravacitinib-BMS-986165-Demonstrated-Superiority-to-Placebo-and-Otezla-apremilast-in-Pivotal-Phase-3-Psoriasis-Study\/default.aspx 2020."},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200304070-00001"},{"key":"cit0077","volume-title":"ACR Late-Breaking Poster Session. 2016 ACR\/ARHP Annual Meeting","author":"Gollooly K","year":"2016"},{"key":"#cr-split#-cit0078.1","unstructured":"Bristol Myers Squibb provides update on phase 2 study of deucravacitinib in patients with moderate to severe ulcerative colitis [internet]. Bristol Myers Squibb 2021 Sep 10 [updated 2022 May 29"},{"key":"#cr-split#-cit0078.2","unstructured":"cited 2022 May 29]. Available from: https:\/\/news.bms.com\/news\/details\/2021\/Bristol-Myers-Squibb-Provides-Update-on-Phase-2-Study-of-Deucravacitinib-in-Patients-With-Moderate-to-Severe-Ulcerative-Colitis\/default.aspx"},{"key":"cit0079","unstructured":"Takeda. Takeda announces positive results in phase 2b study of investigational TAK-279, an oral, once-daily TYK2 inhibitor, in people with moderate-to-severe plaque psoriasis [internet]. 2023. [cited 2023 Apr 23]; Available from: https:\/\/www.takeda.com\/newsroom\/newsreleases\/2023\/takeda-announces-positive-results-in-phase-2b-study-of-investigational-tak-279"},{"key":"cit0080","unstructured":"CliniticalTrial.gov. VTX958 for the treatment of moderately to severely active crohn\u2019s disease (harmony-CD): ClinicalTrial.Gov; [updated 2023 Apr 23; cited 2023 23 Apr 2023]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05688852"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15539"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1186\/s12895-016-0051-4"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v103.5346"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11040293"},{"issue":"12","key":"cit0085","first-page":"719","volume":"56","author":"Mu\u00f1oz-Aceituno E","year":"2020","journal-title":"Med (Kaunas)"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.11.038"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.15.90"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33717-8"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2023.2219054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T09:44:42Z","timestamp":1687599882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2023.2219054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,3]]},"references-count":89,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6,3]]}},"alternative-id":["10.1080\/17512433.2023.2219054"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2023.2219054","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-02-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}